HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced the launch of Over-the-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette Lozenges in the U.S. market.
Nicotine polacrilex 2mg, 4mg; contains sodium, phenylalanine; mint, cherry, or original flavor. Start on quit day. Do not chew or swallow lozenge. Use 2mg if patient smoked first cigarette >30 mins ...
ALLEGAN, Mich. — Perrigo on Wednesday announced that it has received approval from the Food and Drug Administration for its abbreviated new drug applications to market over-the-counter nicotine ...
Dr. Reddy’s latest stor-brand OTC offering is looking to help consumers kick the habit. The company is introducing its private-label equivalent of Nicorette Lozenges, nicotine polacrilex lozenges, in ...
DUBLIN, May 16, 2023 /PRNewswire/ -- Perrigo Company plc (PRGO), a leading provider of Consumer Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug ...
(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced the launch of Over-the-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette Lozenges in the U.S. market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback